Effect of hemodiafiltration and hemodialysis on mortality of patients with end-stage kidney disease: a meta-analysis

Abstract Introduction Previous randomized controlled trials (RCTs) and meta-analyses comparing Hemodiafiltration (HDF) with conventional hemodialysis (HD) on the effectiveness of HDF for mortality in end-stage renal disease (ESRD) patients have yielded contrasting results. Importantly, we sought to...

Full description

Bibliographic Details
Published in:BMC Nephrology
Main Authors: Yifan Zhu, Juan Li, Hulin Lu, Zhanqin Shi, Xiaoyi Wang
Format: Article
Language:English
Published: BMC 2024-10-01
Subjects:
Online Access:https://doi.org/10.1186/s12882-024-03810-9
_version_ 1849683787108057088
author Yifan Zhu
Juan Li
Hulin Lu
Zhanqin Shi
Xiaoyi Wang
author_facet Yifan Zhu
Juan Li
Hulin Lu
Zhanqin Shi
Xiaoyi Wang
author_sort Yifan Zhu
collection DOAJ
container_title BMC Nephrology
description Abstract Introduction Previous randomized controlled trials (RCTs) and meta-analyses comparing Hemodiafiltration (HDF) with conventional hemodialysis (HD) on the effectiveness of HDF for mortality in end-stage renal disease (ESRD) patients have yielded contrasting results. Importantly, we sought to compile the available information to provide the most up-to-date and reliable evidence. Methods We systematically searched PubMed, Embase and Cochrane Library for RCTs up to January 14, 2024. Review Manager 5.3 software was used to analyze relevant data and evaluate the quality of evidence. Results Our study involved 10 randomized controlled trials with 4654 chronic dialysis patients. Compared to hemodialysis, hemodiafiltration demonstrated a reduction in all-cause mortality (relative risk [RR] 0.84, 95% confidence intervals [CI] 0.72–0.99, P = 0.04) and cardiovascular mortality (RR 0.74, 95% CI 0.61–0.90, P = 0.002). However, it did not reduce the rate of sudden death (RR 0.92, 95% CI 0.64–1.34, P = 0.68) and infection-related mortality (RR 0.70, 95% CI 0.47–1.03, P = 0.07). A subgroup analysis revealed that HDF demonstrated superiority over high-flux hemodialysis in terms of all-cause mortality, while not over low-flux hemodialysis (RR 0.81, 95% CI 0.69–0.96, P = 0.01; RR 0.93, 95% CI 0.77–1.12, P = 0.44, respectively). Furthermore, a subgroup analysis for convection volume found that hemodiafiltration with a convection volume of 22 L or more reduced all-cause and cardiovascular mortality (RR 0.76, 95% CI 0.65–0.88, P = 0.0002, RR 0.73, 95% CI 0.54–0.94, P = 0.01, respectively). Conclusion In maintenance hemodialysis patients, hemodiafiltration can reduce mortality compared to conventional hemodialysis. Furthermore, this effect is more pronounced in HDF with high convection volume.
format Article
id doaj-art-4f7d7499ca3249efa46664b2bf09fd7e
institution Directory of Open Access Journals
issn 1471-2369
language English
publishDate 2024-10-01
publisher BMC
record_format Article
spelling doaj-art-4f7d7499ca3249efa46664b2bf09fd7e2025-08-20T02:11:24ZengBMCBMC Nephrology1471-23692024-10-0125111110.1186/s12882-024-03810-9Effect of hemodiafiltration and hemodialysis on mortality of patients with end-stage kidney disease: a meta-analysisYifan Zhu0Juan Li1Hulin Lu2Zhanqin Shi3Xiaoyi Wang4The First People’s Hospital of HuzhouTongxiang Chinese Medicine HospitalThe First People’s Hospital of HuzhouThe First People’s Hospital of HuzhouThe First People’s Hospital of HuzhouAbstract Introduction Previous randomized controlled trials (RCTs) and meta-analyses comparing Hemodiafiltration (HDF) with conventional hemodialysis (HD) on the effectiveness of HDF for mortality in end-stage renal disease (ESRD) patients have yielded contrasting results. Importantly, we sought to compile the available information to provide the most up-to-date and reliable evidence. Methods We systematically searched PubMed, Embase and Cochrane Library for RCTs up to January 14, 2024. Review Manager 5.3 software was used to analyze relevant data and evaluate the quality of evidence. Results Our study involved 10 randomized controlled trials with 4654 chronic dialysis patients. Compared to hemodialysis, hemodiafiltration demonstrated a reduction in all-cause mortality (relative risk [RR] 0.84, 95% confidence intervals [CI] 0.72–0.99, P = 0.04) and cardiovascular mortality (RR 0.74, 95% CI 0.61–0.90, P = 0.002). However, it did not reduce the rate of sudden death (RR 0.92, 95% CI 0.64–1.34, P = 0.68) and infection-related mortality (RR 0.70, 95% CI 0.47–1.03, P = 0.07). A subgroup analysis revealed that HDF demonstrated superiority over high-flux hemodialysis in terms of all-cause mortality, while not over low-flux hemodialysis (RR 0.81, 95% CI 0.69–0.96, P = 0.01; RR 0.93, 95% CI 0.77–1.12, P = 0.44, respectively). Furthermore, a subgroup analysis for convection volume found that hemodiafiltration with a convection volume of 22 L or more reduced all-cause and cardiovascular mortality (RR 0.76, 95% CI 0.65–0.88, P = 0.0002, RR 0.73, 95% CI 0.54–0.94, P = 0.01, respectively). Conclusion In maintenance hemodialysis patients, hemodiafiltration can reduce mortality compared to conventional hemodialysis. Furthermore, this effect is more pronounced in HDF with high convection volume.https://doi.org/10.1186/s12882-024-03810-9HemodiafiltrationHemodialysisCardiovascular mortalityAll-cause mortalityHigh-fluxConvection volume
spellingShingle Yifan Zhu
Juan Li
Hulin Lu
Zhanqin Shi
Xiaoyi Wang
Effect of hemodiafiltration and hemodialysis on mortality of patients with end-stage kidney disease: a meta-analysis
Hemodiafiltration
Hemodialysis
Cardiovascular mortality
All-cause mortality
High-flux
Convection volume
title Effect of hemodiafiltration and hemodialysis on mortality of patients with end-stage kidney disease: a meta-analysis
title_full Effect of hemodiafiltration and hemodialysis on mortality of patients with end-stage kidney disease: a meta-analysis
title_fullStr Effect of hemodiafiltration and hemodialysis on mortality of patients with end-stage kidney disease: a meta-analysis
title_full_unstemmed Effect of hemodiafiltration and hemodialysis on mortality of patients with end-stage kidney disease: a meta-analysis
title_short Effect of hemodiafiltration and hemodialysis on mortality of patients with end-stage kidney disease: a meta-analysis
title_sort effect of hemodiafiltration and hemodialysis on mortality of patients with end stage kidney disease a meta analysis
topic Hemodiafiltration
Hemodialysis
Cardiovascular mortality
All-cause mortality
High-flux
Convection volume
url https://doi.org/10.1186/s12882-024-03810-9
work_keys_str_mv AT yifanzhu effectofhemodiafiltrationandhemodialysisonmortalityofpatientswithendstagekidneydiseaseametaanalysis
AT juanli effectofhemodiafiltrationandhemodialysisonmortalityofpatientswithendstagekidneydiseaseametaanalysis
AT hulinlu effectofhemodiafiltrationandhemodialysisonmortalityofpatientswithendstagekidneydiseaseametaanalysis
AT zhanqinshi effectofhemodiafiltrationandhemodialysisonmortalityofpatientswithendstagekidneydiseaseametaanalysis
AT xiaoyiwang effectofhemodiafiltrationandhemodialysisonmortalityofpatientswithendstagekidneydiseaseametaanalysis